全文获取类型
收费全文 | 3141篇 |
免费 | 212篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 143篇 |
妇产科学 | 122篇 |
基础医学 | 438篇 |
口腔科学 | 46篇 |
临床医学 | 296篇 |
内科学 | 640篇 |
皮肤病学 | 91篇 |
神经病学 | 365篇 |
特种医学 | 72篇 |
外科学 | 342篇 |
综合类 | 32篇 |
一般理论 | 7篇 |
预防医学 | 260篇 |
眼科学 | 59篇 |
药学 | 174篇 |
中国医学 | 16篇 |
肿瘤学 | 240篇 |
出版年
2024年 | 7篇 |
2023年 | 50篇 |
2022年 | 97篇 |
2021年 | 162篇 |
2020年 | 101篇 |
2019年 | 128篇 |
2018年 | 139篇 |
2017年 | 108篇 |
2016年 | 110篇 |
2015年 | 113篇 |
2014年 | 144篇 |
2013年 | 157篇 |
2012年 | 277篇 |
2011年 | 306篇 |
2010年 | 154篇 |
2009年 | 132篇 |
2008年 | 204篇 |
2007年 | 173篇 |
2006年 | 157篇 |
2005年 | 150篇 |
2004年 | 121篇 |
2003年 | 96篇 |
2002年 | 92篇 |
2001年 | 19篇 |
2000年 | 11篇 |
1999年 | 11篇 |
1998年 | 12篇 |
1997年 | 10篇 |
1996年 | 7篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 8篇 |
1992年 | 13篇 |
1991年 | 4篇 |
1990年 | 10篇 |
1988年 | 4篇 |
1987年 | 7篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1980年 | 5篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1974年 | 6篇 |
1973年 | 2篇 |
1970年 | 2篇 |
1969年 | 2篇 |
排序方式: 共有3367条查询结果,搜索用时 15 毫秒
61.
Maya Koronyo-Hamaoui Kandarp Shah Yosef Koronyo Ellen Bernstein Jorge F. Giani Tea Janjulia Keith L. Black Peng D. Shi Romer A. Gonzalez-Villalobos Sebastien Fuchs Xiao Z. Shen Kenneth E. Bernstein 《Current hypertension reports》2014,16(7):1-9
The angiotensin AT2-receptor mediates tissue protective actions. Its regenerative potential has been tested in multiple disease models including models of myocardial infarction. These studies used different experimental approaches in order to detect AT2-receptor-related effects such as AT2-receptor deficiency or overexpression, treatment with an AT1-receptor blocker leading to indirect stimulation of the unopposed AT2-receptor, or studies using AT2-receptor agonists. It is a common finding in these studies that the AT2-receptor improves cardiac function in the early phase post-MI, and that this effect is preserved over periods of up to four months. Depending on the experimental protocol, the AT2R also attenuates post-MI left ventricular remodeling or protects the heart from early left ventricular thinning and rupture. In combination with AT1-receptor blockade or deficiency, post-MI cardiac hypertrophy is reduced. This article reviews studies on the role of the AT2-receptor in myocardial infarction with an emphasis on the most recent data obtained in studies using AT2-receptor agonists. 相似文献
62.
63.
64.
65.
66.
Weijing Cai Maya Ramdas Li Zhu Xue Chen Gary E. Striker Helen Vlassara 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(39):15888-15893
The epidemics of insulin resistance (IR) and type 2 diabetes (T2D) affect the first world as well as less-developed countries, and now affect children as well. Persistently elevated oxidative stress and inflammation (OS/Infl) precede these polygenic conditions. A hallmark of contemporary lifestyle is a preference for thermally processed nutrients, replete with pro-OS/Infl advanced glycation endproducts (AGEs), which enhance appetite and cause overnutrition. We propose that chronic ingestion of oral AGEs promotes IR and T2D. The mechanism(s) involved in these findings were assessed in four generations of C57BL6 mice fed isocaloric diets with or without AGEs [synthetic methyl-glyoxal-derivatives (MG+)]. F3/MG+ mice manifested increased adiposity and premature IR, marked by severe deficiency of anti-AGE advanced glycation receptor 1 (AGER1) and of survival factor sirtuin 1 (SIRT1) in white adipose tissue (WAT), skeletal muscle, and liver. Impaired 2-deoxy-glucose uptake was associated with marked changes in insulin receptor (InsR), IRS-1, IRS-2, Akt activation, and a macrophage and adipocyte shift to a pro-OS/inflammatory (M1) phenotype. These features were absent in F3/MG− mice. MG stimulation of 3T3-L1 adipocytes led to suppressed AGER1 and SIRT1, and altered InsR, IRS-1, IRS-2 phosphorylation, and nuclear factor kappa-light chain enhancer of activated B cells (Nf-κB) p65 acetylation. Gene modulation revealed these effects to be coregulated by AGER1 and SIRT1. Thus, prolonged oral exposure to MG-AGEs can deplete host-defenses AGER1 and SIRT1, raise basal OS/Infl, and increase susceptibility to dysmetabolic IR. Because exposure to AGEs can be decreased, these insights provide an important framework for alleviating a major lifestyle-linked disease epidemic. 相似文献
67.
68.
69.
70.
Chiu Y Ostor AJ Hammond A Sokoll K Anderson M Buch M Ehrenstein MR Gordon P Steer S Bruce IN 《Clinical rheumatology》2012,31(6):1005-1012
Patients in England and Wales with rheumatoid arthritis (RA) receive treatment from the National Health Service (NHS) with therapies approved by the European Medicines Agency (EMA), under guidance from the National Institute for Health and Clinical Excellence (NICE). This document overviews the current NICE guidelines for the treatment of RA and identifies scenarios when such guidance may not represent the optimum management strategy for individual patients. Specifically, we consider the use of tocilizumab or abatacept as the most appropriate treatments for some patients. In such scenarios, it may be possible for the clinician to secure access to the required therapy through an application procedure known as an 'individual funding request', the process of which is described in detail here. At present, it is unclear the extent to which the proposed reform of the NHS will affect the role of NICE in providing guidance and setting standards of care. Until the full impact of the proposed changes are realized, individual funding requests will remain a valuable way of securing the optimal treatment for all patients suffering from RA. 相似文献